Emerging role of DYRK family protein kinases as regulators of protein stability in cell cycle control
- PMID: 22918246
- PMCID: PMC3466549
- DOI: 10.4161/cc.21404
Emerging role of DYRK family protein kinases as regulators of protein stability in cell cycle control
Abstract
Dual-specificity tyrosine phosphorylation-regulated kinases (DYRKs) constitute an evolutionarily conserved family of protein kinases with key roles in the control of cell proliferation and differentiation. Members of the DYRK family phosphorylate many substrates, including critical regulators of the cell cycle. A recent report revealed that human DYRK2 acts as a negative regulator of G1/S transition by phosphorylating c-Jun and c-Myc, thereby inducing ubiquitination-mediated degradation. Other DYRKs also function as cell cycle regulators by modulating the turnover of their target proteins. DYRK1B can induce reversible cell arrest in a quiescent G0 state by targeting cyclin D1 for proteasomal degradation and stabilizing p27 (Kip1). The DYRK2 ortholog of C. elegans, MBK-2, triggers the proteasomal destruction of oocyte proteins after meiosis to allow the mitotic divisions in embryo development. This review summarizes the accumulating results that provide evidence for a general role of DYRKs in the regulation of protein stability.
Figures

Similar articles
-
Inhibitors of dual-specificity tyrosine phosphorylation-regulated kinases (DYRK) exert a strong anti-herpesviral activity.Antiviral Res. 2017 Jul;143:113-121. doi: 10.1016/j.antiviral.2017.04.003. Epub 2017 Apr 9. Antiviral Res. 2017. PMID: 28400201
-
Multiple functions of DYRK2 in cancer and tissue development.FEBS Lett. 2019 Nov;593(21):2953-2965. doi: 10.1002/1873-3468.13601. Epub 2019 Sep 18. FEBS Lett. 2019. PMID: 31505048 Review.
-
A novel DYRK1B inhibitor AZ191 demonstrates that DYRK1B acts independently of GSK3β to phosphorylate cyclin D1 at Thr(286), not Thr(288).Biochem J. 2014 Jan 1;457(1):43-56. doi: 10.1042/BJ20130461. Biochem J. 2014. PMID: 24134204
-
Protein quality control of DYRK family protein kinases by the Hsp90-Cdc37 molecular chaperone.Biochim Biophys Acta Mol Cell Res. 2021 Sep;1868(10):119081. doi: 10.1016/j.bbamcr.2021.119081. Epub 2021 Jun 18. Biochim Biophys Acta Mol Cell Res. 2021. PMID: 34147560
-
The diverse functions of DYRK2 in response to cellular stress.Histol Histopathol. 2024 Nov;39(11):1427-1434. doi: 10.14670/HH-18-744. Epub 2024 Apr 8. Histol Histopathol. 2024. PMID: 38656683 Review.
Cited by
-
A Bioinformatics Evaluation of the Role of Dual-Specificity Tyrosine-Regulated Kinases in Colorectal Cancer.Cancers (Basel). 2022 Apr 18;14(8):2034. doi: 10.3390/cancers14082034. Cancers (Basel). 2022. PMID: 35454940 Free PMC article.
-
B cell class switch recombination is regulated by DYRK1A through MSH6 phosphorylation.Nat Commun. 2023 Mar 16;14(1):1462. doi: 10.1038/s41467-023-37205-5. Nat Commun. 2023. PMID: 36927854 Free PMC article.
-
A KLF4-DYRK2-mediated pathway regulating self-renewal in CML stem cells.Blood. 2019 Nov 28;134(22):1960-1972. doi: 10.1182/blood.2018875922. Blood. 2019. PMID: 31515251 Free PMC article.
-
Updating dual-specificity tyrosine-phosphorylation-regulated kinase 2 (DYRK2): molecular basis, functions and role in diseases.Cell Mol Life Sci. 2020 Dec;77(23):4747-4763. doi: 10.1007/s00018-020-03556-1. Epub 2020 May 27. Cell Mol Life Sci. 2020. PMID: 32462403 Free PMC article. Review.
-
N-Benzylated 5-Hydroxybenzothiophene-2-carboxamides as Multi-Targeted Clk/Dyrk Inhibitors and Potential Anticancer Agents.Cancers (Basel). 2024 May 27;16(11):2033. doi: 10.3390/cancers16112033. Cancers (Basel). 2024. PMID: 38893153 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous